Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

被引：12
|
作者：
Pereyra-Rodriguez, J. J. [1 ,17 ]
Herranz, P. [2 ]
Figueras-Nart, I [3 ]
Perez, B. [4 ]
Elosua, M. [5 ]
Munera-Campos, M. [6 ]
Melgosa-Ramos, J. [7 ]
Zaragoza, V [8 ]
Silvestre, J. F. [9 ]
Campos-Dominguez, M. [10 ]
Guilabert, A. [11 ]
Miquel, J. [12 ]
Alcantara-Luna, S. [13 ]
de la Cueva, P. [14 ]
Serra-Baldrich, E. [15 ]
Armario-Hita, J. C. [16 ]
Rodriguez, Jose Juan Pereyra
机构：
[1] Univ Hosp Virgen Rocio, Dept Dermatol, Seville, Spain
[2] Univ Hosp La Paz, Dept Dermatol, Madrid, Spain
[3] Univ Hosp Bellvitge, Dept Dermatol, Barcelona, Spain
[4] Univ Hosp Ramon & Cajal, Dept Dermatol, Madrid, Spain
[5] Univ Hosp Puerta Hierro, Dept Dermatol, Madrid, Spain
[6] Univ Hosp Germans Trias i Pujol, Dept Dermatol, Badalona, Spain
[7] Univ Hosp Doctor Peset, Dept Dermatol, Valencia, Spain
[8] Univ Hosp Gen Valencia, Dept Dermatol, Valencia, Spain
[9] Univ Hosp Alicante, Dept Dermatol, Alicante, Spain
[10] Univ Hosp Gregorio Maranon, Dept Dermatol, Madrid, Spain
[11] Gen Hosp Granollers, Dept Dermatol, Barcelona, Spain
[12] Univ Hosp Arnau Vilanova, Dept Dermatol, Valencia, Spain
[13] Juan Ramon Jimenez Hosp, Dept Dermatol, Huelva, Spain
[14] Infanta Leonor Hosp, Dept Dermatol, Madrid, Spain
[15] St Pau Hosp, Dept Dermatol, Barcelona, Spain
[16] Univ Hosp Puerto Real, Dept Dermatol, Puerto Real, Spain
[17] Univ Hosp Virgen del Roci, Dept Dermatol, Avda Manuel Siurot S-N, Seville 41013, Spain
来源：
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2023年 / 33卷 / 03期
关键词：
Atopic dermatitis; Atopic eczema; Upadacitinib; JAK-inhibitors; Real-world evidence; DOUBLE-BLIND; ADOLESCENTS; PLACEBO; ADULTS;
D O I：
10.18176/jiaci.0831
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：211 / 213
页数：3
相关论文
共 50 条
  • [1] The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan
    Hagino, Teppei
    Saeki, Hidehisa
    Kanda, Naoko
    JOURNAL OF DERMATOLOGY, 2022, 49 (11) : 1158 - 1167
  • [2] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
    Zeng, Linxi
    Feng, Sen
    Yao, Lulu
    Wang, Bin
    Zhang, Guoqiang
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 734 - 740
  • [3] Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-Analysis
    Meher, Bikash R.
    Mishra, Archana
    Behera, Biswanath
    Ponnusamy, Subashri
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [4] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis
    Huang, Yuanjie
    Cai, Limin
    Wu, Xuerui
    Chen, Chen
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 725 - 733
  • [5] Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
    Lytvyn, Yuliya
    Mufti, Asfandyar
    Abduelmula, Abrahim
    Sachdeva, Muskaan
    Maliyar, Khalad
    Georgakopoulos, Jorge R.
    Yeung, Jensen
    PHARMACEUTICS, 2022, 14 (11)
  • [6] A real-world Australian experience of upadacitinib for the treatment of severe atopic dermatitis
    Tran, Vanessa
    Ross, Gayle
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (04) : e352 - e356
  • [7] Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [8] Cost per NNT for upadacitinib in the treatment of patients with moderate-severe atopic dermatitis in Italy
    Chiricozzi, Andrea
    Costanzo, Antonio
    Levi, Anna
    Parretta, Federica
    Ravasio, Roberto
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2024, 11 : 38 - 50
  • [9] Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: A network meta-analysis
    Wan, Huiying
    Jia, Haiping
    Xia, Tian
    Zhang, Dingding
    DERMATOLOGIC THERAPY, 2022, 35 (09)
  • [10] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
12345